Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- The Week In Review: Deals, Development And Financials
Sep 28, 2008 01:59 PM
- Mixed Earnings & Data
Aug 13, 2008 10:01 AM
- Analyst Comments: Qiagen, Virgin Media, Priceline, NovaMed
Aug 07, 2008 02:57 PM
- Searching For Positive Catalysts
Jun 16, 2008 09:57 AM
- Slightly Better Than Expected CPI
Jun 13, 2008 09:25 AM
- Battle For Control
May 08, 2008 10:14 AM
- Analyst Comments: Somaxon, Bellus Health, Qiagen, CNET Networks, Salix Pharma, VeriFone
May 07, 2008 05:47 PM
- Analyst Comments: Bayer, ArvinMeritor, Qiagen, Satyam Computer, DRS Technologies
Apr 30, 2008 12:45 PM
- Mixed Earnings Signals
Apr 23, 2008 09:46 AM
- Chock Full Of Earnings
Apr 21, 2008 10:46 AM
- Mexican Department of Public Health to Launch Screening for Human Papillomavirus (HPV), Cause of Cervical Cancer
Nov 19, 2008 02:01 AM
- SciQuest Announces Strategic Alliance With QIAGEN
Nov 12, 2008 10:56 AM
- QIAGEN Reports Strong Third Quarter 2008 Results
Nov 10, 2008 04:01 PM
- QIAGEN Introduces CE-marked Molecular Assay for the Cancer Biomarker K-ras
Nov 10, 2008 04:01 PM
- Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2008 Financial Results Call Set for November 11
Nov 03, 2008 09:01 AM
- Reminder - Register Your Company Now for the 2009 IR Global Rankings
Oct 24, 2008 12:53 PM
- Nobel Prize to HPV Researcher Highlights Importance of Cervical Cancer Screening and Prevention
Oct 06, 2008 04:22 PM
- QIAGEN Acquires Biosystems Business From Biotage
Oct 01, 2008 02:00 AM
- First Published Study of New HPV Test for Developing Countries Shows High Accuracy in Predicting Cervical Disease
Sep 21, 2008 06:31 PM
- QIAGEN to Present At the 2008 UBS Global Life Sciences Conference
Sep 18, 2008 09:01 AM
Analyst Ratings
|
|
Share Performance
|
Period
|
QGEN
|
Compare to S&P
|
| YTD |
-23.37 %
|
25.54 %
|
| 4 Weeks |
13.11 %
|
22.26 %
|
| 12 Weeks |
-18.12 %
|
13.49 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 5.00 %
|
|
EPS Growth in Last Year: 23.53 %
|
|
Sales Growth in Last Quarter: 5.93 %
|
|
Sales Growth in Last Quarter: 30.67 %
|
|
|
